Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Preventive Vaccines Market to Reach $55 Billion by 2021: Market Overview & Industry Trends - Research and Markets

Research and Markets
Posted on: 06 Sep 17

The "Global Preventive Vaccines Market- Trends and Forecasts 2017 - 2022" report has been added to Research and Markets' offering.

The global preventive vaccines market accounted for a value of USD 27.6 billion in 2015 and is expected to reach USD 55 billion by 2021, growing at a CAGR of 12.4% during the forecast period from 2016 to 2021.

The vaccines market is different from any other commodity market. Compared to the pharmaceutical market, the vaccines market is relatively small, although growing fast. The vaccines market is rather concentrated on both supply and demand sides. It is highly regulated and largely dependent on public purchasers and donor policies. The vaccines market has very distinct features that increase the complexity of assessing and understanding pricing and procurement in their context. It is made up of individual markets for individual vaccines or vaccine types, each with its own specificities, particularly on the supply side.

New candidates for vaccination against cancer and HIV, which are under development, are also projected to hit the magical milestone. Multinational vaccine companies historically have conducted much of the innovation, research, and development in the field of vaccine production. The companies have used their significant revenues, global size, and deeper expertise to fund these R&D efforts. New technologies are also being introduced to curb the time and expense incurred on new vaccine discovery and production. However, despite the success of vaccines, infectious diseases are still a major cause of illnesses worldwide. At least 40 major infectious diseases are still uncontrolled by vaccination.

Companies Mentioned:

  • Merck & Co.
  • GlaxoSmithKline
  • Sanofi
  • Pfizer
  • Emergent BioSolutions
  • Takeda
  • Astellas Pharma
  • AstraZeneca
  • Mitsubishi Tanabe

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry Trends

6. Drivers, Restraints, Opportunities and Challenges

7. Global Preventive Vaccines Market - Segmentation

8. Global Preventive Vaccines market by Geography - Regional shares and forecasts

9. Competitive Landscape

10. Company Profiles

11. Analyst Outlook for Investment Opportunities

12. Future Outlook of the Market

For more information about this report visit

View source version on

Business Wire

Last updated on: 06/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.